Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-10-31
1987-12-22
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514394, 546118, 548333, 548334, A61K 3144, C07D47104, C07D48704
Patent
active
047147628
ABSTRACT:
Novel substituted benzimidazol-2-yl-phenoxyalkanoic acids, salts and esters thereof and 3H-imidazo[4,5-b]pyridin-2-yl phenoxy-alkanoic acid, salts, and esters which are useful as antiarteriosclerotic agents are disclosed. The compounds elevate the high density lipoprotein fraction of cholesterol and also lower the low density lipoprotein fraction of cholesterol. Methods for preparing and using the compounds are included.
REFERENCES:
patent: 3674836 (1972-07-01), Creger
patent: 3707566 (1972-12-01), Creger et al.
Gordon, T. et al., High Density Lipoprotein as a Protective Factor Against Coronary Heart Disease, May 1977, Amn. J. Med., 62, pp. 707-714, JAMA 251, pp. 361 and 365, 1984.
Hoefle Milton L.
Holmes Ann
Stratton Charlotte D.
Anderson Elizabeth M.
Dentz Bernard I.
Jiles Henry R.
Warner-Lambert & Company
LandOfFree
Antiarteriosclerotic substituted benzimidazol-2-yl-and 3H-imidaz does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiarteriosclerotic substituted benzimidazol-2-yl-and 3H-imidaz, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiarteriosclerotic substituted benzimidazol-2-yl-and 3H-imidaz will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-819391